Vnitr Lek 2007, 53(11):1139-1141

N-terminální peptid pro-BNP a endotelin u hemodialyzovaných nemocných - editorial

J. Racek
Ústav klinické biochemie a hematologie Lékařské fakulty UK a FN Plzeň, přednosta prof. MUDr. Jaroslav Racek, DrSc.

Received: September 2, 2007; Published: November 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Racek J. N-terminální peptid pro-BNP a endotelin u hemodialyzovaných nemocných - editorial. Vnitr Lek. 2007;53(11):1139-1141.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 2004; 50: 33-50. Go to original source... Go to PubMed...
    2. Hammerer-Lercher A, Puschendorf B, Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. Clin Lab 2001; 47: 265-277. Go to PubMed...
    3. Davenport AP, Maguire JJ Endothelin. Handbook of Experimental Pharmacology 2006; 176: 295-329. Go to original source... Go to PubMed...
    4. Ludka O, ©pinar J, Vítovcová L et al. Variabilita plazmatických hladin big endotelinu a NT-proBNP u nemocných se srdečním selháním v chronickém hemodialyzačním programu. Vnitř Lék 2007; 53(11): 1177-1181. Go to PubMed...
    5. Ludka O, ©pinar J, Vítovcová L et al. Význam stanovení NT-proBNP a big endotelinu pro diagnostiku chronického srdečního selhání u nemocných v pravidelném hemodialyzačním programu. Vnitř Lék 2007; 53: 38-45. Go to PubMed...
    6. Kohse KP, Feifel K, Mayer-Wehrstein R Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol 1993; 40: 83-90. Go to PubMed...
    7. Ishizaka Y, Yamamoto Y, Fukunaga T et al. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 1994; 24: 461-472. Go to original source... Go to PubMed...
    8. Leowattana W, Ong-Ajyooth L, Taruangsri P et al. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients. J Med Assoc Thai 2003; 86(Suppl 1): S52-S58. Go to PubMed...
    9. Sommerer C, Beimler J, Schwenger V et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 2007; 37: 350-356. Go to original source... Go to PubMed...
    10. Racek J, Králová H, Trefil Let al. Brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) in chronic haemodialysis patients. Nephron Clin Pract 2006; 103: c162-c172. Go to original source... Go to PubMed...
    11. Ishikura F, Ando Y, Park YD et al. Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis. Ren Fail 1996; 18: 261-270. Go to original source... Go to PubMed...
    12. Nitta K, Kawashima A, Yumura W et al. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol 1998; 18: 411-415. Go to original source... Go to PubMed...
    13. Clerico A, Caprioli R, Del Ry S et al. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest 2001; 24: 24-30. Go to original source... Go to PubMed...
    14. Wahl HG, Graf S, Renz H et al. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004; 50: 1071-1074. Go to original source... Go to PubMed...
    15. Dutin G, Boudjeltia S, Soltani Z et al. The changes in NT-proBNP plasma concentrations during dialysis are highly dependent of the dialysis membrane ultrafiltration coefficient. Clin Chim Acta 2007; 376: 237-239. Go to original source... Go to PubMed...
    16. Zoccali C, Mallamaci F, Benedetto FA et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-1515. Go to original source... Go to PubMed...
    17. Naganuma T, Sugimura K, Wada S et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 2002; 22: 437-444. Go to original source... Go to PubMed...
    18. Carr SJ, Bavanandan S, Fentum B et al. Prognostic potential of brain natriuretic peptide (BNP) in predialysis chronic kidney disease patients. Clin Sci (Lond) 2005; 109: 75-82. Go to original source... Go to PubMed...
    19. Longhitano JP, Henrich WL, Light PD et al. N-Terminal pro brain natriuretic peptide (NT-proBNP) predicts left ventricular function and mortality in hemodialysis patients but not cardiac death: a two-year outcome study. J Am Coll Cardiol 2002; 39(Suppl 2): 269-269. Go to original source...
    20. Madsen LH, Ladefoged S, Corell P et al. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 2007; 71: 548-554. Go to original source... Go to PubMed...
    21. Koyama H, Tabata T, Nishzawa Y et al. Plasma endothelin levels in patients with uraemia. Lancet 1989; 1: 991-992. Go to original source... Go to PubMed...
    22. Seeberger AO, Ahlborg G, Hemsen A et al. Hemodynamic effects of Endothelin-1 and Big endothelin-1 in chronic hemodialysis patients. J Am Soc Nephrol 1999; 10: 1037-1044. Go to original source... Go to PubMed...
    23. Deray G, Carayon A, Maestre G et al. Endothelin in chronic renal failure. Nephrol Dial Transplant 1992; 7: 300-305. Go to original source... Go to PubMed...
    24. Stefanidis I, Wurth P, Mertens PR et al. Plasma endothelin-1 in hemodialysis treatment - the influence of hypertension. J Cardiovasc Pharmacol 2004; 44: S43-S48. Go to original source... Go to PubMed...
    25. Voss DM, Lynn KL, Bultimore AL et al. Changes in blood pressure and vasoactive hormones during volume expansion in stable patients on chronic haemodialysis. Nephrology 1995; 1: 577-581. Go to original source...
    26. Surdacki A, Sulowicz W, Wieczorek-Surdacka E et al. Effect of a hemodialysis session on plasma levels of endothelin-1 in hypertensive and normotensive subjects with end-stage renal failure. Nephron 1999; 81: 31-36. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.